Open AccessDurable response of immune checkpoint inhibitor after failure of gemcitabine-based chemotherapy for a patient with metastatic biliary tract cancer
Author(s) -
Chiun Hsu,
Chien-Huai Chuang
Publication year - 2021
Publication title -
journal of cancer research and practice
Language(s) - English
Resource type - Journals
eISSN - 2589-0425
pISSN - 2311-3006
DOI - 10.4103/jcrp.jcrp_22_21
Subject(s) - medicine , pembrolizumab , gemcitabine , oncology , chemotherapy , cancer , pancreatic cancer , adverse effect , immunotherapy